Literature DB >> 11353589

The interface of psychiatric disorders and diabetes mellitus.

M K Popkin1, E A Colon.   

Abstract

This paper reviews recent developments at the interface between psychiatric disorders and diabetes mellitus. A Medline search for the interval 1994 to 2000 was conducted, and the review addresses selected content from the search involving the following: 1) neuroleptic induced diabetes and the associated issue of diabetes and schizophrenia; 2) developments concerning various facets of the relationship of diabetes mellitus and depressive disorder; and 3) recent findings with regard to specific diabetic complications and their links to psychiatry.

Entities:  

Mesh:

Year:  2001        PMID: 11353589     DOI: 10.1007/s11920-001-0060-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  39 in total

1.  Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial.

Authors:  P J Lustman; K E Freedland; L S Griffith; R E Clouse
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Family history of type 2 diabetes in schizophrenic patients.

Authors:  S Mukherjee; D B Schnur; R Reddy
Journal:  Lancet       Date:  1989-03-04       Impact factor: 79.321

3.  Sexual function in men with diabetes type 2: association with glycemic control.

Authors:  J H Romeo; A D Seftel; Z T Madhun; D C Aron
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Diabetes mellitus in schizophrenic patients.

Authors:  S Mukherjee; P Decina; V Bocola; F Saraceni; P L Scapicchio
Journal:  Compr Psychiatry       Date:  1996 Jan-Feb       Impact factor: 3.735

5.  Depression and risk for onset of type II diabetes. A prospective population-based study.

Authors:  W W Eaton; H Armenian; J Gallo; L Pratt; D E Ford
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

6.  Use of ECT in treatment of depression in patients with diabetes mellitus.

Authors:  R D Weiner; T E Sibert
Journal:  J Clin Psychiatry       Date:  1996-03       Impact factor: 4.384

7.  Diabetic ketoacidosis associated with clozapine treatment.

Authors:  M S Koval; L J Rames; S Christie
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

8.  Severe hyperglycemia associated with high doses of clozapine.

Authors:  A Kamran; P M Doraiswamy; J L Jane; E B Hammett; L Dunn
Journal:  Am J Psychiatry       Date:  1994-09       Impact factor: 18.112

9.  Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus.

Authors:  M de Groot; A M Jacobson; J A Samson; G Welch
Journal:  J Psychosom Res       Date:  1999-05       Impact factor: 3.006

10.  Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome.

Authors:  M Kovacs; D S Obrosky; D Goldston; A Drash
Journal:  Diabetes Care       Date:  1997-01       Impact factor: 19.112

View more
  1 in total

1.  Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.

Authors:  Igor Elman; David Rott; Alan I Green; Daniel D Langleben; Scott E Lukas; David S Goldstein; Alan Breier
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.